These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17138792)

  • 21. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
    Warren T; Harris J; Brennan CA
    Clin Infect Dis; 2004 Nov; 39 Suppl 5():S258-66. PubMed ID: 15494897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving the care of patients with genital herpes.
    Drake S; Taylor S; Brown D; Pillay D
    BMJ; 2000 Sep; 321(7261):619-23. PubMed ID: 10977846
    [No Abstract]   [Full Text] [Related]  

  • 23. Valacyclovir for the treatment of genital herpes.
    Brantley JS; Hicks L; Sra K; Tyring SK
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):367-76. PubMed ID: 16771614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial.
    Abudalu M; Tyring S; Koltun W; Bodsworth N; Hamed K
    Clin Infect Dis; 2008 Sep; 47(5):651-8. PubMed ID: 18637755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
    Wald A; Selke S; Warren T; Aoki FY; Sacks S; Diaz-Mitoma F; Corey L
    Sex Transm Dis; 2006 Sep; 33(9):529-33. PubMed ID: 16540883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
    Tyring SK; Baker D; Snowden W
    J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
    Handsfield HH; Warren T; Werner M; Phillips JA
    Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genital herpes.
    Jungmann E
    Clin Evid; 2005 Dec; (14):1937-49. PubMed ID: 16620476
    [No Abstract]   [Full Text] [Related]  

  • 29. Antiviral therapy for genital herpes in nonpregnant and pregnant women.
    Baker DA
    Int J Fertil Womens Med; 1998; 43(5):243-8. PubMed ID: 9863617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study.
    Kim HN; Wald A; Harris J; Almekinder J; Heitman C; Corey L
    Sex Transm Dis; 2008 Feb; 35(2):124-8. PubMed ID: 17921912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of herpes simplex virus type 2 transmission with antiviral therapy.
    Corey L; Ashley R;
    Herpes; 2004 Aug; 11 Suppl 3():170A-174A. PubMed ID: 15319087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral treatment of genital herpes.
    Apoola A; Radcliffe K
    Int J STD AIDS; 2004 Jul; 15(7):429-33. PubMed ID: 15228725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Herpes genitalis, an underrated disease?].
    Hautarzt; 1997 Jan; 48(1 Suppl Herpes):1-8. PubMed ID: 9402418
    [No Abstract]   [Full Text] [Related]  

  • 35. Recurrent erythema multiforme unresponsive to acyclovir prophylaxis and responsive to valacyclovir continuous therapy.
    Kerob D; Assier-Bonnet H; Esnault-Gelly P; Blanc F; Saiag P
    Arch Dermatol; 1998 Jul; 134(7):876-7. PubMed ID: 9681359
    [No Abstract]   [Full Text] [Related]  

  • 36. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
    Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A
    Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genital herpes.
    Jungmann E
    Clin Evid; 2005 Jun; (13):1987-2001. PubMed ID: 16135318
    [No Abstract]   [Full Text] [Related]  

  • 38. Guidance on management of asymptomatic neonates born to women with active genital herpes lesions.
    Kimberlin DW; Baley J; ;
    Pediatrics; 2013 Feb; 131(2):383-6. PubMed ID: 23378604
    [No Abstract]   [Full Text] [Related]  

  • 39. Labeling updates to genital herpes drug.
    FDA Consum; 2003; 37(6):3. PubMed ID: 14983803
    [No Abstract]   [Full Text] [Related]  

  • 40. [Chronic suppressive therapy in recurrent herpes labia with valacyclovir in adolescents. Our experience].
    Ruiz-Villaverde R; Sánchez-Cano D
    An Pediatr (Barc); 2009 Nov; 71(5):473-4. PubMed ID: 19783490
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.